NASDAQ · PEARW
Pear Therapeutics, Inc.
Healthcare · Medical - Healthcare Information Services
$0.01
Up+$0.00 (+0.00%)
Updated Sep 18, 2026, 1:43 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.09M
- P/E ratio
- -0.17
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 471.84K
- Avg. volume
- 0
Price performance
PEARW price history
1M range · 0 trading sessions · Daily adjusted prices
PEARW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PEARW news
The latest Smart Investors Daily articles mentioning PEARW.
Stock researchCompany · Overview
PEARW research
Overview
Company profile and research snapshot.
Company profile
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
